WGSGeneDx Holdings Corp.

Healthcare

$67.31-48% 1Y

$67.31

$34.5152 weeks$167.51

Is it safe?

Mixed

Forensics clean, with a caveat: a safe balance sheet and clean books, but heavy debt (BB) and big price swings.

2 good, 2 to watch, 2 neutral

SurvivalSafe zone

Financially healthy, low distress risk Altman Z-score, a bankruptcy-risk model from five balance-sheet ratios.

Honest booksLow risk

Reported earnings show no manipulation flags Beneish M-score, a forensic model that detects earnings-manipulation patterns (receivables outrunning sales, margins slipping, accrual-heavy profit).

Quality6 / 9

Mixed fundamental signals Piotroski F-score, nine pass/fail tests of year-over-year financial health across profitability, balance sheet and efficiency. 7 to 9 is strong, 0 to 3 weak.

Insider conviction-$1.8M

Insiders were net sellers (-$1.8M, 90 days to Oct 8, 2026), selling is often routine.

Credit gradeBBderived · Jun 30, 2026

Net cash, but unprofitable, speculative. A rule of thumb on leverage, not a credit rating.

Drawdown risk99% volderived · Oct 9, 2026

Large price swings, high volatility. Worst drawdown -100% · now 60% below its 52-week high.

Unless marked, from SEC EDGAR, as of Dec 31, 2025.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Volatilitybottom 5% of the market

Max drawdownbottom 1% of the market

Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.

Can WGS take a bad year?

GeneDx Holdings Corp. holds $36M more cash than debt, and is burning $19M a quarter, about 1.8 years of cover.

$36M

Net cash

Net debt / EBITDA: net cash
Net debt / EBITDA · no net borrowings to measure against earnings
Altman Z-score: 3.10
Altman Z-score · safe zone, above 3
Cash runway: 1.8 years
Cash runway · burning $19M a quarter at the current rate